← Eichor
Study identifier: NCT05444283 Synced from ClinicalTrials.gov · July 28, 2026
● Recruiting

Genomic Predictors of Recurrent Pregnancy Loss

Condition: Recurrent Pregnancy Loss  ·  Sponsor: Yale University

PhaseN/A
Planned participants500
Who can joinAll sexes, 18 Years to 50 Years
Healthy volunteersYes

About this study

The overall goals of this proposal are to determine the genetic architecture of recurrent pregnancy loss (RPL) and to discover genomic predictors of RPL.

This description comes directly from the study's public registry record.

Talk to the study team

Yong-Hui Jiang, MD, PhD  ·  2037852429  ·  yong-hui.jiang@yale.edu

Heping Zhang, PhD  ·  12037855185  ·  heping.zhang@yale.edu

Always discuss trial participation with your own doctor first.

Locations (10)

University of ColoradoAurora, Colorado, United StatesRecruiting
Yale UniversityNew Haven, Connecticut, United StatesRecruiting
Northwestern UniversityChicago, Illinois, United StatesRecruiting
University of ChicagoChicago, Illinois, United StatesActive Not Recruiting
Johns Hopkins UniversityBaltimore, Maryland, United StatesRecruiting
Wayne State UniversityDetroit, Michigan, United StatesRecruiting
Columbia UniversityNew York, New York, United StatesRecruiting
Pennsylvania State UniversityHershey, Pennsylvania, United StatesRecruiting
University of Texas at AustinAustin, Texas, United StatesRecruiting
University of Texas at San AntonioSan Antonio, Texas, United StatesRecruiting

Follow this study

Get one email when the public record changes — results posted, or the study's status changes. Nothing else, ever.

We email about this public record only. Unsubscribe anytime with one click. Never medical advice.

Is this your study? This page was generated automatically from the public registry record. Sponsors can claim it — free — to add branding and verified contact routing. Claim this page →

This page is independently generated by Eichor from the public ClinicalTrials.gov record and re-synced daily. It is not the sponsor's official website unless claimed. Nothing here is medical advice; eligibility is always determined by the study team — talk to your own doctor first.

Source record: clinicaltrials.gov/study/NCT05444283